{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:39:16Z","timestamp":1789609156638,"version":"build-2803163510"},"reference-count":17,"publisher":"BMJ","issue":"6252","license":[{"start":{"date-parts":[[1980,11,22]],"date-time":"1980-11-22T00:00:00Z","timestamp":343699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med J"],"published-print":{"date-parts":[[1980,11,22]]},"abstract":"<jats:p>Plasma exchanges were combined with human factor VIII concentrate therapy in the treatment of major bleeding episodes in five patients with haemophilia A and factor VIII inhibitors. All patients had a good clinical response to combined treatment. Inhibitor levels showed satisfactory falls before rapid secondary increases of inhibitor levels took place. A sixth patient with von Willebrand's disease and a factor VIII clotting activity inhibitor was successfully prepared for operation using plasma exchange. Postoperative haemostasis and healing were normal. In two patients the plasma exchanges were relatively more effective than the administered human factor VIII in reducing the levels of factor VIII inhibitor. Combined plasma exchange and human factor VIII treatment may offer a rapidly effective means of reducing factor VIII inhibitor levels in this group of patients, together with significant saving of costs.<\/jats:p>","DOI":"10.1136\/bmj.281.6252.1388","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T18:32:30Z","timestamp":1238697150000},"page":"1388-1389","source":"Crossref","is-referenced-by-count":19,"title":["Plasma exchange and human factor VIII concentrate in managing haemophilia A with factor VIII inhibitors."],"prefix":"10.1136","volume":"281","author":[{"given":"R T","family":"Wensley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R F","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Burn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I W","family":"Delamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1980,11,22]]},"reference":[{"key":"ref_1","article-title":"Treatment of haemophilia A and B and von Willebrands disease","author":"R, I.Biggs","year":"1978","unstructured":"I Biggs R. Treatment of haemophilia A and B and von Willebrands disease. London: Blackwell, 1978:195."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2141.1973.tb05728.x","article-title":"The treatment of patients who have factor VIII antibodies","volume":"24","author":"Rizza, C.R.; Biggs, R.","year":"1973","unstructured":"Rizza CR, Biggs R. The treatment of patients who have factor VIII antibodies. BrJ Haematol 1973;24:65-82.","journal-title":"BrJ Haematol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0028-1086103","article-title":"Management of patients with factor VIII and IX inhibitors","volume":"1","author":"Penner, J.A.; Kelly, P.E.","year":"1975","unstructured":"Penner JA, Kelly PE. Management of patients with factor VIII and IX inhibitors. Semin Thromb Hemostas 1975;1:386-99.","journal-title":"Semin Thromb Hemostas"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJM197411142912014","article-title":"The treatment of inhibitors to factor VIII with activated prothrombin concentrate","volume":"291","author":"Sultan, Y.; Bronet, J.C.; Debre, P.","year":"1974","unstructured":"Sultan Y, Bronet JC, Debre P. The treatment of inhibitors to factor VIII with activated prothrombin concentrate. N Engl J7 Med 1974;291:1087.","journal-title":"N Engl J7 Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM197407252910402","article-title":"Activated prothrombin concentrate for patients with factor VIII inhibitors","volume":"291","author":"Kurczyaski, E.M.; Penner, J.A.","year":"1974","unstructured":"Kurczyaski EM, Penner JA. Activated prothrombin concentrate for patients with factor VIII inhibitors. NEnglJ Med 1974;291:164-7.","journal-title":"NEnglJ Med"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0140-6736(54)92208-4","article-title":"Bovine anti-haemophilic globulin in the treatment of haemophilia","volume":"i:","author":"MacFarlane, R.G.; Biggs, R.; Bidwell, E.","year":"1954","unstructured":"MacFarlane RG, Biggs R, Bidwell E. Bovine anti-haemophilic globulin in the treatment of haemophilia. Lancet 1954;i: 1316-9.","journal-title":"Lancet"},{"key":"ref_7","first-page":"120","article-title":"The treatment of patients having spontaneously occurring antibodies to anti-haemophilic factor (factor VIII)","volume":"28","author":"Rizza, C.R.; Edgcumbe, J.O.P.; Pitney, W.R.; Child, S.A.","year":"1972","unstructured":"Rizza CR, Edgcumbe JOP, Pitney WR, Child SA. The treatment of patients having spontaneously occurring antibodies to anti-haemophilic factor (factor VIII). Thrombosis et Diathesis Haemorrhagia 1972;28: 120-8.","journal-title":"Thrombosis et Diathesis Haemorrhagia"},{"key":"ref_8","first-page":"225","article-title":"Immunosuppression in the treatment of haemophiliacs with antibodies to factor VIII","volume":"1974","author":"Dormandy, K.M.","year":"1974","unstructured":"Dormandy KM. Immunosuppression in the treatment of haemophiliacs with antibodies to factor VIII. In: Ulutin ON, Peake IR, eds. Proceedings of the IXth congress of the worldfederation of haemophilia, Istanbul, 1974. Amsterdam: Excerpta Medica, 1974:225.","journal-title":"Proceedings of the IXth congress of the worldfederation of haemophilia; Amsterdam: Excerpta Medica"},{"key":"ref_9","first-page":"763","article-title":"Serial plasmaphoresis in a haemophiliac with antibodies to F VIII","volume":"30","author":"Colcroft, R.; Tamagrim, G.; Dormandy, K.M.","year":"1972","unstructured":"Colcroft R, Tamagrim G, Dormandy KM. Serial plasmaphoresis in a haemophiliac with antibodies to F VIII. Y Clin Pathol 1972;30:763-5.","journal-title":"Y Clin Pathol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0038-1651858","article-title":"Treatment of antifactor VIII antibodies","volume":"38","author":"Blatt, P.M.; White, G.C.; McMillan, C.W.; Roberts, H.R.","year":"1977","unstructured":"Blatt PM, White GC, McMillan CW, Roberts HR. Treatment of antifactor VIII antibodies. Thromb Haemostas 1977;38:514-23.","journal-title":"Thromb Haemostas"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1182\/blood.V26.6.805.805","article-title":"A clinical and experimental study of acquired inhibitors to factor VIII","volume":"26","author":"Roberts, H.R.; Scales, M.B.; Madison, J.T.; Webster, W.P.; Penick, G.D.","year":"1965","unstructured":"Roberts HR, Scales MB, Madison JT, Webster WP, Penick GD. A clinical and experimental study of acquired inhibitors to factor VIII. Blood 1965;26:805-18.","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V41.1.113.113","article-title":"Successful management of a subdural haematoma in a haemophiliac with an anti-factor VIII antibody","volume":"41","year":"1973","unstructured":"Edson JR, McArthur JR, Branda RF, McCullough JJ, Chow SR. Successful management of a subdural haematoma in a haemophiliac with an anti-factor VIII antibody. Blood 1973;41:113-22.","journal-title":"Blood"},{"key":"ref_13","first-page":"182","article-title":"Treatment of haemorrhages in a haemophiliac with factor VIII inhibitor","volume":"104","author":"Angelkort, B.; Strerner, K.H.","year":"1979","unstructured":"Angelkort B, Strerner KH. Treatment of haemorrhages in a haemophiliac with factor VIII inhibitor. Dtsch Med Wochenschr 1979;104:182.","journal-title":"Dtsch Med Wochenschr"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/blood.V46.4.535.535","article-title":"Treatment of life-threatening haemorrhage due to acquired factor VIII inhibitor","volume":"46","author":"Pintado, T.; Taswell, H.F.; Bowie, E.J.W.","year":"1975","unstructured":"Pintado T, Taswell HF, Bowie EJW. Treatment of life-threatening haemorrhage due to acquired factor VIII inhibitor. Blood 1975;46: 535-41.","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2141.1959.tb04049.x","article-title":"A method for the study of antihaemophilic globulin inhibitors with reference to six cases","volume":"5","author":"Biggs, R.; Bidwell, E.","year":"1959","unstructured":"Biggs R, Bidwell E. A method for the study of antihaemophilic globulin inhibitors with reference to six cases. BrJ Haematol 1959;5:379-95.","journal-title":"BrJ Haematol"},{"issue":"7","key":"ref_16","first-page":"215","article-title":"A one-stage factor VIII (anti-haemophilic globulin) assay and its use on venous and capillary plasma","volume":"1962","author":"Hardisty, R.M.; MacPherson, J.C.","unstructured":"Hardisty RM, MacPherson JC. A one-stage factor VIII (anti-haemophilic globulin) assay and its use on venous and capillary plasma. Thromb et Diathesis Haemorrhagia 1962;7:215-29.","journal-title":"Thromb et Diathesis Haemorrhagia"},{"key":"ref_17","article-title":"Accepted","year":"1980","unstructured":"(Accepted 13 October 1980)"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.281.6252.1388","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.281.6252.1388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:21:42Z","timestamp":1765459302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.281.6252.1388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,11,22]]},"references-count":17,"journal-issue":{"issue":"6252","published-online":{"date-parts":[[1980,11,22]]},"published-print":{"date-parts":[[1980,11,22]]}},"alternative-id":["10.1136\/bmj.281.6252.1388"],"URL":"https:\/\/doi.org\/10.1136\/bmj.281.6252.1388","relation":{},"ISSN":["0007-1447","1468-5833"],"issn-type":[{"value":"0007-1447","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1980,11,22]]}}}